Your browser doesn't support javascript.
loading
Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months.
Dummer, Reinhard; Lear, John T; Guminski, Alex; Leow, Liang Joo; Squittieri, Nicholas; Migden, Michael.
Afiliação
  • Dummer R; Department of Dermatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland. Electronic address: reinhard.dummer@usz.ch.
  • Lear JT; Department of Dermatology, Salford Royal National Health Service Foundation Trust, Salford, United Kingdom.
  • Guminski A; Department of Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Leow LJ; Department of Dermatology, St. Vincent's Private Hospital, Sydney, New South Wales, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia; St Vincent's & Mater Clinical School, University of Notre Dame Australia, Sydney, New South Wales, Austr
  • Squittieri N; Medical Affairs Oncology, Sun Pharmaceutical Industries, Inc, Princeton, New Jersey, United States.
  • Migden M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
J Am Acad Dermatol ; 84(4): 1162-1164, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33358380

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Cutâneas / Compostos de Bifenilo / Carcinoma Basocelular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Cutâneas / Compostos de Bifenilo / Carcinoma Basocelular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article